Published August 1, 2024 | Version v1

Concordant inter-laboratory derived concentrations of ceramides in human plasma reference materials via authentic standards

  • 1. Singapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, Singapore 117456, Singapore.;Precision Medicine Translational Research Programme and Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119077, Singapore.;Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-National University of Singapore (NUS) Medical School, Singapore 169857, Singapore.
  • 2. Institute for Bio- and Geosciences (IBG-5), Forschungszentrum Juelich GmbH, 52428 Juelich, Germany.;Department of Analytical Chemistry, University of Vienna, Vienna, Austria.
  • 3. Singapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, Singapore 117456, Singapore.

Description

Concordant inter-laboratory derived concentrations of ceramides in human plasma reference materials via authentic standards

In this community effort, we compared measurements between 34 laboratories from 19 countries, utilizing mixtures of labelled authentic synthetic standards, to quantify by mass spectrometry four clinically used ceramide species in the NIST (National Institute of Standards and Technology) human blood plasma Standard Reference Material (SRM) 1950, as well as new suite of candidate plasma reference materials (RM 8231). Participants either utilized a provided validated method (SOP) and/or their method of choice (OTHER). Mean concentration values, and intra- and inter-laboratory coefficients of variation (CV) were calculated using single-point and multi-point calibrations, respectively.

The attached file "ILS-Ceramide-Ring-Trial-Datasets.csv"  and the table below map the lab number (LabNum) used in the manuscript in all plots to the originally assigned submission Id (LabId) used in the anonymized reports containing the peak areas submitted by each lab for their SOP (Standard) and / or OTHER (Preferred) workflow. The table below provides further information on the separation used (LC), the mass analyzer type (QQQ=Triple Quads and Traps, Orbitrap, TOF) and the associated mass analyzer resolution (LowRes, HighRes), and links each LabNum to the corresponding dataset name and Zenodo DOI, if available. In order to retain the anonymity of all participating labs w.r.t. the submitted datasets, only the converted mzML files are provided in the linked submissions. Please note that labs were free to choose whether they wanted to disclose their MS data or not. Thus, missing datasets indicate that the corresponding lab did not provide their raw / mzML data. 

All reports together with the code for analysis and visualization, reproducing the figures in the manuscript, are available under the following doi: https://zenodo.org/doi/10.5281/zenodo.10081970. This links to releases of the following GitHub repository: https://github.com/lifs-tools/ils-ceramide-ring-trial

Ring Trial mzML Datasets

LabNum LabId Protocol LC MassAnalyzerType MassAnalyzerResolution DatasetName DOI
1 02b SOP RP QQQ LowRes Lab_01_SOP 10.5281/zenodo.13134264
2 3 OTHER RP QQQ LowRes Lab_02_OTHER 10.5281/zenodo.13145059
3 4 SOP RP QQQ LowRes Lab_03_SOP 10.5281/zenodo.13134437
4 5 OTHER RP QQQ LowRes Lab_04_OTHER  
5 7 OTHER RP Orbitrap HighRes Lab_05_OTHER 10.5281/zenodo.13134439
6 9 OTHER FIA QQQ LowRes Lab_06_OTHER 10.5281/zenodo.13134441
7 10a SOP RP QQQ LowRes Lab_07_SOP 10.5281/zenodo.13134445
7 10b OTHER RP QQQ LowRes Lab_07_OTHER 10.5281/zenodo.13134443
8 12 SOP RP QQQ LowRes Lab_08_SOP 10.5281/zenodo.13134447
9 13 OTHER RP QQQ LowRes Lab_09_OTHER  
10 14 SOP RP QQQ LowRes Lab_10_SOP  
11 15 SOP RP QQQ LowRes Lab_11_SOP 10.5281/zenodo.13134449
12 16 OTHER RP Orbitrap HighRes Lab_12_OTHER 10.5281/zenodo.13134451
13 17a OTHER RP TOF HighRes Lab_13_OTHER  
14 18a SOP RP QQQ LowRes Lab_14_SOP 10.5281/zenodo.13135617
14 18b SOP RP QQQ LowRes Lab_14_SOP 10.5281/zenodo.13135617
15 19 SOP RP QQQ LowRes Lab_15_SOP 10.5281/zenodo.13135625
16 20a SOP RP QQQ LowRes Lab_16_SOP  
16 20b OTHER RP QQQ LowRes Lab_16_OTHER  
17 21 SOP RP QQQ LowRes Lab_17_SOP  
18 22 SOP RP QQQ LowRes Lab_18_SOP 10.5281/zenodo.13135627
19 23 SOP RP QQQ LowRes Lab_19_SOP 10.5281/zenodo.13135629
20 24 SOP RP QQQ LowRes Lab_20_SOP  
21 25 SOP RP QQQ LowRes Lab_21_SOP 10.5281/zenodo.13244007
22 26a OTHER FIA Orbitrap HighRes Lab_22_OTHER  
22 26b OTHER FIA QQQ LowRes Lab_22_OTHER  
23 27 SOP RP QQQ LowRes Lab_23_SOP 10.5281/zenodo.13135632
24 28 SOP RP QQQ LowRes Lab_24_SOP 10.5281/zenodo.13135634
25 29a SOP RP TOF HighRes Lab_25_SOP 10.5281/zenodo.13136167
25 29b OTHER SFC QQQ LowRes Lab_25_OTHER 10.5281/zenodo.13135638
26 30 SOP RP QQQ LowRes Lab_26_SOP 10.5281/zenodo.13136171
27 31 SOP RP QQQ LowRes Lab_27_SOP 10.5281/zenodo.13136176
28 32 OTHER RP TOF HighRes Lab_28_OTHER  
29 33 OTHER RP QQQ LowRes Lab_29_OTHER  
30 34 SOP RP QQQ LowRes Lab_30_SOP  
31 35 OTHER RP QQQ LowRes Lab_31_OTHER  
32 36 SOP RP QQQ LowRes Lab_32_SOP 10.5281/zenodo.13166454
33 37 OTHER RP QQQ LowRes Lab_33_OTHER 10.5281/zenodo.13732469
34 38 SOP RP QQQ LowRes Lab_34_SOP 10.5281/zenodo.13324807

Files

ILS-Ceramide-Ring-Trial-Datasets.csv

Files (1.1 kB)

Name Size Download all
md5:b1375fda5c84217df46b6de5a44a488f
1.1 kB Preview Download

Additional details